Carl Pabo
Carl O. Pabo is considered a "world leader in issues involving the structure and design of DNA-binding protein."[1] He is now founder and president of Humanity 2050, a nonprofit institute. [2] [3]
Education
- B.S. (summa cum laude) from Yale, Molecular Biophysics and Biochemistry in 1974
- Ph.D. from Harvard, Biochemistry and Molecular Biology in 1980.
Career
Dr. Pabo has been a Professor at the Johns Hopkins University School of Medicine (1982-1991) and at the Massachusetts Institute of Technology (1991-2001) and an Investigator with the Howard Hughes Medical Institute (1986-2001).[5] He's been a Visiting Professor at Caltech, Stanford, Berkeley and Harvard.[6] At Caltech, he taught a course called “The World in 2050.” [7]
He was Chief Scientific Officer at Sangamo BioSciences from 2001–2003.[8]
In 2018, he founded Humanity 2050 to “to advocate a more comprehensive, coherent way of thinking about the human future.” [9] He also serves as a scientific advisor for NanoDimension. [10]
Awards, Honors
Pabo became a Guggenheim Fellow in 2005.[11] He is a member of the National Academy of Sciences[12] and of the American Academy of Arts and Sciences.[13]
He has also won the Protein Society Young Investigator Award and the Pfizer Award in enzymology.[14]
References
- ^ Carl Pabo - Professor @ Johns Hopkins University School of Medicine
- ^ Project Syndicate Bio
- ^ Humanity 2050
- ^ Protean Futures LLC
- ^ Carl O. Pabo, PhD | HHMI.org
- ^ Protean Futures
- ^ NAS Member Bio
- ^ Protean Futures
- ^ Humanity 2050 Blog
- ^ Carl O. Pabo resume
- ^ "John Simon Guggenheim Foundation | All Fellows".
- ^ NAS profile
- ^ Protean Futures
- ^ Four professors elected to NAS membership
   | This biographical article related to medicine in the United States is a stub. You can help Wikipedia by expanding it. |
 | This article about an American biochemist is a stub. You can help Wikipedia by expanding it. |